Literature DB >> 22169158

Factors affecting the diagnostic delay in amyotrophic lateral sclerosis.

Eleonora Cellura1, Rossella Spataro, Alfonsa Claudia Taiello, Vincenzo La Bella.   

Abstract

BACKGROUND: Although amyotrophic lateral sclerosis (ALS) is a relentlessly progressive disorder, early diagnosis allows a prompt start with the specific drug riluzole and an accurate palliative care planning. ALS at onset may however mimic several disorders, some of them treatable (e.g., multifocal motor neuropathy) or epidemiologically more frequent (e.g., cervical myelopathy).
OBJECTIVE: To study the delay from onset to diagnosis in a cohort of ALS patients and to the variables that may affect it.
METHODS: We performed a retrospective analysis of the diagnostic delays in a cohort of 260 patients affected by ALS (M/F = 1.32) followed at our tertiary referral ALS Center between 2000 and 2007.
RESULTS: The median time from onset to diagnosis was 11 months (range: 6-21) for the whole ALS cohort, 10 months (range: 6-15) in bulbar-onset (n = 65) and 12 months (range: 7-23) in spinal-onset (n = 195) patients (p = 0.3). 31.1% of patients received other diagnoses before ALS and this led to a significant delay of the correct diagnosis in this group (other diagnoses before ALS, n = 81: median delay, 15 months [9.75-24.25] vs ALS, n = 179, median delay, 9 months [6-15.25], p < 0.001).
CONCLUSIONS: The diagnostic delay in ALS is about one year, besides the growing number of tertiary centres and the spread of information about the disease through media and internet. Cognitive errors based on an incorrect use of heuristics might represent an important contributing factor. Furthermore, the length of the differential diagnosis from other disorders and delays in referral to the neurologist seems to be positively associated with the delay in diagnosis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22169158     DOI: 10.1016/j.clineuro.2011.11.026

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  32 in total

1.  Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: results from five prospective cohort studies.

Authors:  Elinor Fondell; Éilis J O'Reilly; Kathryn C Fitzgerald; Guido J Falcone; Marjorie L McCullough; Michael J Thun; Yikyung Park; Laurence N Kolonel; Alberto Ascherio
Journal:  Amyotroph Lateral Scler       Date:  2012-08-07

2.  Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS).

Authors:  Sabrina Paganoni; Eric A Macklin; Alexandra Lee; Alyssa Murphy; Judith Chang; Amanda Zipf; Merit Cudkowicz; Nazem Atassi
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-07-01       Impact factor: 4.092

3.  Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.

Authors:  Radhika Raheja; Keren Regev; Brian C Healy; Maria Antonietta Mazzola; Vanessa Beynon; Felipe Von Glehn; Anu Paul; Camilo Diaz-Cruz; Taha Gholipour; Bonnie I Glanz; Pia Kivisakk; Tanuja Chitnis; Howard L Weiner; James D Berry; Roopali Gandhi
Journal:  Muscle Nerve       Date:  2018-03-25       Impact factor: 3.217

4.  CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.

Authors:  Daniela Rossi; Paolo Volanti; Liliana Brambilla; Tiziana Colletti; Rossella Spataro; Vincenzo La Bella
Journal:  J Neurol       Date:  2018-01-10       Impact factor: 4.849

Review 5.  MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis.

Authors:  Frank Cloutier; Alier Marrero; Colleen O'Connell; Pier Morin
Journal:  J Mol Neurosci       Date:  2014-11-30       Impact factor: 3.444

6.  Population-based surveillance of amyotrophic lateral sclerosis in New Jersey, 2009-2011.

Authors:  Heather Jordan; Jerald Fagliano; Lindsay Rechtman; Daniel Lefkowitz; Wendy Kaye
Journal:  Neuroepidemiology       Date:  2014-10-16       Impact factor: 3.282

7.  The expression discrepancy and characteristics of long non-coding RNAs in peripheral blood leukocytes from amyotrophic lateral sclerosis patients.

Authors:  Yujiao Yu; Dejiang Pang; Chunyu Li; Xiaojing Gu; Yongping Chen; Ruwei Ou; Qianqian Wei; Huifang Shang
Journal:  Mol Neurobiol       Date:  2022-04-02       Impact factor: 5.590

8.  Natural history of muscle cramps in amyotrophic lateral sclerosis.

Authors:  James B Caress; Stephanie L Ciarlone; Elizabeth A Sullivan; Leah P Griffin; Michael S Cartwright
Journal:  Muscle Nerve       Date:  2015-09-28       Impact factor: 3.217

Review 9.  Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Chafic Karam; Nanette Joyce; Richard Bedlack; Gregory T Carter
Journal:  NeuroRehabilitation       Date:  2015       Impact factor: 2.138

10.  How much medicine do spine surgeons need to know to better select and care for patients?

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2012-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.